ExodusPoint Capital Management »

Aclaris Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.0M 147k 6.85
2022-12-31 $232k 15k 15.73
2021-06-30 $509k 29k 17.57
2021-03-31 $3.5M 141k 25.20
2020-12-31 $1.4M 223k 6.47

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
CMS Energy Corporation (CMS)
Select Sector Spdr Tr Energy Call Option (XLE)
PPL Corporation (PPL)
Exelon Corporation (EXC)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NiSource (NI)
Vmware Cl A Com
Exxon Mobil Corporation (XOM)
Select Sector Spdr Tr Financial Put Option (XLF)
Microsoft Corporation Call Option (MSFT)

View all positions for ExodusPoint Capital Management

Top funds holding Aclaris Therapeutics

BML Capital Management
Citadel Advisors
Vanguard Group
Millennium Management
D. E. Shaw & Co
Tang Capital Management
GSA Capital Partners
Two Sigma Investments
Two Sigma Advisers
Monaco Asset Management SAM
Deutsche Bank Aktiengesellschaft
Jacobs Levy Equity Management
Samsara BioCapital
Goldman Sachs Group
Citigroup

View all funds holding Aclaris Therapeutics